New menopause drug for hot flashes gets FDA approval
More than 80% of women experience hot flashes during menopause, the FDA noted.
Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than 80% of women experience hot flashes during menopause, the FDA noted.
FDA approved the first drug to treat agitation associated with Alzheimer's disease: Rexulti, a brexpiprazole oral tablet
The FDA has fast-tracked a new ALS treatment for patients whose disease is genetic. Patients who have been getting the injections report a slowing of their disease progression and even renewed strength.
Dr. Jason Slakter of Vitreous Retina Macula Consultants of New York is the first to administer Syfovre, a groundbreaking treatment for geographic atrophy
Memo Therapeutics, a biotech company developing therapeutic antibodies, has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to AntiBKV.